Today

Agents

Chat

Arena

Discover

More

App

Viking Therapeutics Q2 EPS USD -1.1 Vs. IBES Estimate USD -1.25 - VKTX News | Rallies

Viking Therapeutics Q2 EPS USD -1.1 Vs. IBES Estimate USD -1.25

VKTX•2026-07-29

Viking Therapeutics reports quarterly results

Jul 29 (Reuters) - Viking Therapeutics Q2 operating expenses USD 132.597 million.

Q2 income from operations USD -132.597 million vs. IBES estimate USD -150.3 million
Q2 net income USD -128.022 million vs. IBES estimate USD -144.7 million

Related News

CDT Equity issues 32,110 shares at $3.27 each in unregistered sale to service provider

CDT•2026-07-29

United States Lime & Minerals Q2 Revenue USD 99.126 Million

USLM•2026-07-29

Service Corporation Q2 beats estimates on higher prices; narrows FY profit view

•

2026-07-29

Zions Bancorp EVP Derek Steward disposes of 894 common shares valued at $62,255.1

ZION•2026-07-29

Vistra declares quarterly dividend of $0.23 per share on common stock

VST•2026-07-29